Nitsch L, Shirvani Samani O, Silaschi M, Schafigh M, Zimmer S, Petzold G C, Kindler C, Bode F J
Department of Neurology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Division of Vascular Neurology, Department of Neurology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Neurol Res Pract. 2023 Apr 6;5(1):13. doi: 10.1186/s42466-023-00239-7.
Infective endocarditis (IE) is a serious condition with a high mortality, represents a rare cause of stroke and an increased risk of intracranial hemorrhage. In this single center study, we characterize stroke patients with IE. We were interested in risk factors for intracranial hemorrhage and outcome of patients with intracranial hemorrhage compared to patients with ischemic stroke.
Patients with IE and symptomatic ischemic stroke or intracranial hemorrhage admitted to our hospital between January 2019 and December 2022 were included in this retrospective study.
48 patients with IE and ischemic stroke or intracranial hemorrhage were identified. 37 patients were diagnosed with ischemic stroke, 11 patients were diagnosed with intracranial hemorrhage. The intracranial hemorrhage occurred within the first 12 days after admission. We identified Staphylococcus aureus detection and thrombocytopenia as risk factors for hemorrhagic complications. An increased in-hospital mortality in patients with intracranial hemorrhage (63.6% vs. 22%, p = 0.022) was found, whereas patients with ischemic stroke and patients with intracranial hemorrhage do not differ regarding favorable clinical outcome (27% vs. 27.3%, p = 1.0). 27.3% patients with intracranial hemorrhage and 43.2% patients with ischemic stroke underwent cardiac surgery. Overall, 15.7% new ischemic strokes occurred after valve reconstruction, whereas no new intracranial hemorrhage was observed.
We found an increased in-hospital mortality in patients with intracranial hemorrhage. Beside thrombocytopenia, we identified S. aureus detection as a risk factor for intracranial hemorrhage.
感染性心内膜炎(IE)是一种严重疾病,死亡率高,是中风的罕见病因,且颅内出血风险增加。在这项单中心研究中,我们对患有IE的中风患者进行了特征描述。我们关注颅内出血的危险因素以及颅内出血患者与缺血性中风患者的预后情况。
本回顾性研究纳入了2019年1月至2022年12月期间我院收治的患有IE且有症状性缺血性中风或颅内出血的患者。
共识别出48例患有IE且有缺血性中风或颅内出血的患者。37例被诊断为缺血性中风,11例被诊断为颅内出血。颅内出血发生在入院后的前12天内。我们确定金黄色葡萄球菌检测和血小板减少为出血性并发症的危险因素。发现颅内出血患者的院内死亡率增加(63.6%对22%,p = 0.022),而缺血性中风患者和颅内出血患者在良好临床结局方面无差异(27%对27.3%,p = 1.0)。27.3%的颅内出血患者和43.2%的缺血性中风患者接受了心脏手术。总体而言,瓣膜重建后发生新的缺血性中风的比例为15.7%,而未观察到新的颅内出血。
我们发现颅内出血患者的院内死亡率增加。除血小板减少外,我们确定金黄色葡萄球菌检测为颅内出血的一个危险因素。